Ulrik B. Andersen

2-Oleoyl Glycerol Is a GPR119 Agonist and Signals GLP-1 Release in Humans

Katrine Bagge Hansen, Mette M. Rosenkilde, Filip K. Knop et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 285 citations

Life Sciences, Endocrinology, Pharmacology +17

The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients

Lasse Bremholm, Mads Hornum, Ulrik B. Andersen et al. · Regulatory Peptides · 2011 · 109 citations

Medicine, Physiology, Surgery +12

Effect of <scp>GLP</scp> ‐1 receptor agonist treatment on body weight in obese antipsychotic‐treated patients with schizophrenia: <scp>a</scp> randomized, placebo‐controlled trial

Pelle L. Ishøy, Filip K. Knop, Brian V. Broberg et al. · Diabetes Obesity and Metabolism · 2016 · 90 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial

Jens Christian Laursen, Niels Søndergaard Heinrich, Joana Mendes Lopes de Melo et al. · EClinicalMedicine · 2021 · 81 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Paget's disease of the bone after treatment with Denosumab: A case report

Peter Schwarz, Anne Qvist Rasmussen, Torben Kvist et al. · Bone · 2012 · 60 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +11